A detailed history of X Square Capital, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, X Square Capital, LLC holds 19,568 shares of BHC stock, worth $144,607. This represents 0.07% of its overall portfolio holdings.

Number of Shares
19,568
Previous 19,568 -0.0%
Holding current value
$144,607
Previous $136,000 17.65%
% of portfolio
0.07%
Previous 0.06%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$7.77 - $10.61 $373,231 - $509,651
-48,035 Reduced 71.05%
19,568 $192,000
Q4 2023

Feb 09, 2024

SELL
$6.53 - $8.23 $84 - $106
-13 Reduced 0.02%
67,603 $542,000
Q2 2023

Aug 14, 2023

SELL
$5.72 - $8.8 $16,427 - $25,273
-2,872 Reduced 4.07%
67,616 $541,000
Q3 2021

Nov 12, 2021

SELL
$25.04 - $30.06 $187,699 - $225,329
-7,496 Reduced 9.61%
70,488 $1.97 Million
Q2 2021

Aug 16, 2021

SELL
$27.43 - $32.7 $891,968 - $1.06 Million
-32,518 Reduced 29.43%
77,984 $2.28 Million
Q1 2021

May 13, 2021

BUY
$21.37 - $34.38 $25,109 - $40,396
1,175 Added 1.07%
110,502 $3.51 Million
Q4 2020

Feb 12, 2021

SELL
$15.31 - $21.12 $97,938 - $135,104
-6,397 Reduced 5.53%
109,327 $2.27 Million
Q3 2020

Nov 02, 2020

SELL
$14.88 - $20.13 $277,318 - $375,162
-18,637 Reduced 13.87%
115,724 $1.8 Million
Q2 2020

Aug 13, 2020

BUY
$13.31 - $20.51 $1,144 - $1,763
86 Added 0.06%
134,361 $2.46 Million
Q1 2020

May 19, 2020

BUY
$12.98 - $30.25 $1.74 Million - $4.06 Million
134,275 New
134,275 $2.08 Million
Q1 2019

May 15, 2019

SELL
$20.23 - $26.29 $1.06 Million - $1.38 Million
-52,602 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$20.64 - $25.67 $1.09 Million - $1.35 Million
52,602 New
52,602 $1.35 Million

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track X Square Capital, LLC Portfolio

Follow X Square Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of X Square Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on X Square Capital, LLC with notifications on news.